Investment funds: PRC firms
Rising stars
Rising stars with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Leading individuals
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
She has also helped many domestic and international funds to invest in China through various structures across industrials such as life science, medical and pharmaceutical, health care, telecommunications, new energy, semi-conductor etc. In addition, Amy Dai has helped several issuers in their initial public offering on both the international stock exchanges such as Nasdaq, AIM, Hong Kong Stock Exchange, and Taiwan stock exchange. Amy Dai worked for Boehringer Ingelheim (China), a top fifteen multinational pharmaceutical company, as the legal counsel in 2009 and 2010.
Comparative Guides
View
Comparative Guides
China: Alternative Investment Funds
China
Contribution fromGlobal Law OfficeGlobal Law Office